5Noble S,Benfield P.Citalopram:A review of its pharmacology,clinical efficacy and tolerability in the treatment of depression[J].CNS Drugs,1997,8(6):410.
6方积乾，统计与预测，1998年，增刊，40页
7柯惠新，调查研究中的统计分析法，1992年
8MilneRJ,Goakl.Citalopram:a reviewof its pharmacodynamic and pharmacokinetic properties,and therapeutic potential in depressive illness.Drugs 1991;41:450
4van den BERG MD, OLDEHINKEL AJ, BOUHUYS AL, et al. Depression in later life, three etiologically different subgroups[J]. J Affect Disord, 2001, 65(1): 19-26.
5KYLE C J, PETERSEN HEH, OVERO KF. Comparison of the tolerability andefficaey of citalopram and amitriptyline in elderly depressed patients treated in general practice [J]. Depress Anxiety, 1998, 8(4): 147-153.
6KARLSSON I, GODDERIS J, AUGUSTO DE MENDONA LIMA C, et al. A randomised double- blind comparison of the efficacy and safety of citalopram compared to mianserin in elderly, depressed patients with or without mild to moderate dementia[J]. Int J Geriatr Psychiatry, 2000, 15(4) : 295-305.
7NAVARRO V, GASTO C, TORRES X, et al. Citalopram versus nortriptyline in late- life depression: a 12- week randomized single- blind study[J]. Acta Psychiatr Scand, 2001, 103 (6): 435-440.
8ALLARD P, GRAM L, TIMDAHL K, et al. Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression : a double - blind, randomised 6 - month comparative trial with eitalopram[J]. Int J Geriatr Psychiatry, 2004, 19(12): 1123-1130.
9RAMPELLO L, CHIECHIO S, NICOLETFI G, et al Prediction of the response to citalopram and reboxetine in post- stroke depressed patients[J]. Psychopharmacology (Berl), 2004, 173 (1-2) : 73-78.
10ROSENBERG C, LAURITZEN L, BRIX J, et al. Citalopram versus amitriptyline in elderly depressed patients with or without mild cognitive dysfunction: a danish muhicentre trial in general practice[J]. Psychopharmacol Bull, 2007, 40(1): 63-73.
